LabGenius CTO Leonard Wossnig on combining synthetic biology, high-throughput assays and machine learning to design T cell engagers, the next generation of antibody cancer drugs.

Pangea Bio co-founders John Bogossian and Sona Chandra on using AI to mine the natural world for new central nervous system drugs.

Jona founder and CEO Leo Grady on the trillions of microbial cells that live in and on us, and how AI is being used to make sense of the microbiome and what it means for health.

Modicus Prime founder Taylor Chartier on using machine learning to catch contamination and quality problems in drug manufacturing before defective medicines ever reach patients.

Nassib Chamoun of the Health Data Analytics Institute on moving healthcare AI past forecasts and demos to concrete cases where it measurably improves clinical decisions and patient outcomes.